What Is the Role of Concentrated Insulin in Diabetes Management?
Document Type
Article
Publication Date
6-1-2016
Description
Two concentrated analog insulins, long-acting insulin glargine U-300 (Toujeo) and rapid-acting insulin lispro (Humalog U-200), were recently approved by the FDA. Providers must be aware of clinical differences in these new product formulations compared with their nonconcentrated formulations, so that they can select appropriate patients for these products and minimize drug errors.
Citation Information
Mospan, Cortney M.. 2016. What Is the Role of Concentrated Insulin in Diabetes Management?. Journal of the American Academy of Physician Assistants. Vol.29(6). 16-18. https://doi.org/10.1097/01.JAA.0000483103.42630.8b PMID: 27228041 ISSN: 1547-1896